Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cancer Gene Therapy Market to reach USD 7.22 billion by the end of 2029

Global Cancer Gene Therapy Market Size study & Forecast, by Type (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by End Use (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others) and Regional Analysis, 2022-2029

Product Code: HLSDT-70959284
Publish Date: 29-01-2023
Page: 200

Global Cancer Gene Therapy Market is valued at approximately USD 1.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 19.99% over the forecast period 2022-2029. Cancer gene therapy is a new treatment modality that assists in the introduction of new genes into a cancerous cell or the nearby tissue that leads to cell death or slows the growth of cancer. This treatment technique is flexible and a variety of genes and vectors are being utilized in clinical trials that present positive results, which is gaining huge popularity as a novel method for treating human ailments. The flourishing development of the pharmaceutical industry, surging demand for novel cancer therapeutics, and rising government support are the primary factors that are fostering market demand across the globe.

The rising incidences of cancer globally are a key driving factor for market growth. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the Cancer Gene Therapy Market. Moreover, the increasing technological advancements in cancer gene therapy, as well as growing R&D investments, are creating lucrative opportunities for market growth in the foreseen years. However, the high cost associated with gene therapy and unwanted immune responses is hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cancer Gene Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the presence of well-established market players and increasing investment in healthcare facilities in the region. Whereas, Europe is expected to grow at the highest CAGR during the forecast period. Factors such as rising research funding for novel therapeutics by government bodies, as well as growing demand for novel therapeutics are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Abeona Therapeutics Inc.
Asklepios BioPharmaceutical Inc.
Bluebird bio Inc.
GlaxoSmithKlineInc.
Introgen TherapeuticsInc.
MerckKGaA
BioCancell Inc.
Elevate Bio Inc.
Genelux Corporation
OncoGenex Pharmaceuticals Inc.
Recent Developments in the Market:
 In January 2022, Ori Biotech Ltd. publicized that the company has achieved above USD 100 million in funding in a Series B funding round, which is planned to use for the expansion of key personnel to support the launch of its innovative cell and gene therapy manufacturing platform.
 In June 2021, Eisai and Bristol Myers Squibb entered collaborative agreement to form and marketing of MORAb-202, Eisai’s ADC for advanced solid tumors.
Global Cancer Gene Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent to up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End Use:
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Cancer Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Cancer Gene Therapy Market, by Type, 2019-2029 (USD Billion)
1.2.3. Cancer Gene Therapy Market, by End Use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Gene Therapy Market Dynamics
3.1. Cancer Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Surging demand for novel cancer therapeutics
3.1.1.2. Rising incidences of cancer globally
3.1.2. Market Challenges
3.1.2.1. High cost is associated with gene therapy
3.1.2.2. Unwanted immune responses
3.1.3. Market Opportunities
3.1.3.1. Increasing technological advancements in cancer gene therapy
3.1.3.2. Growing R&D investments
Chapter 4. Global Cancer Gene Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Gene Therapy Market, by Type
6.1. Market Snapshot
6.2. Global Cancer Gene Therapy Market by Type, Performance – Potential Analysis
6.3. Global Cancer Gene Therapy Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Cancer Gene Therapy Market, Sub Segment Analysis
6.4.1. Oncolytic Virotherapy
6.4.2. Gene Induced Immunotherapy
6.4.3. Gene Transfer
Chapter 7. Global Cancer Gene Therapy Market, by End Use
7.1. Market Snapshot
7.2. Global Cancer Gene Therapy Market by End Use, Performance – Potential Analysis
7.3. Global Cancer Gene Therapy Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
7.4. Cancer Gene Therapy Market, Sub Segment Analysis
7.4.1. Research Institutes
7.4.2. Biopharmaceutical Companies
7.4.3. Diagnostic Centers
7.4.4. Others
Chapter 8. Global Cancer Gene Therapy Market, Regional Analysis
8.1. Cancer Gene Therapy Market, Regional Market Snapshot
8.2. North America Cancer Gene Therapy Market
8.2.1. U.S. Cancer Gene Therapy Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End Use breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cancer Gene Therapy Market
8.3. Europe Cancer Gene Therapy Market Snapshot
8.3.1. U.K. Cancer Gene Therapy Market
8.3.2. Germany Cancer Gene Therapy Market
8.3.3. France Cancer Gene Therapy Market
8.3.4. Spain Cancer Gene Therapy Market
8.3.5. Italy Cancer Gene Therapy Market
8.3.6. Rest of Europe Cancer Gene Therapy Market
8.4. Asia-Pacific Cancer Gene Therapy Market Snapshot
8.4.1. China Cancer Gene Therapy Market
8.4.2. India Cancer Gene Therapy Market
8.4.3. Japan Cancer Gene Therapy Market
8.4.4. Australia Cancer Gene Therapy Market
8.4.5. South Korea Cancer Gene Therapy Market
8.4.6. Rest of Asia Pacific Cancer Gene Therapy Market
8.5. Latin America Cancer Gene Therapy Market Snapshot
8.5.1. Brazil Cancer Gene Therapy Market
8.5.2. Mexico Cancer Gene Therapy Market
8.6. Rest of The World Cancer Gene Therapy Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abeona Therapeutics Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Asklepios BioPharmaceutical Inc.
9.2.3. Bluebird bio Inc.
9.2.4. GlaxoSmithKlineInc.
9.2.5. Introgen TherapeuticsInc.
9.2.6. MerckKGaA
9.2.7. BioCancell Inc.
9.2.8. Elevate BioInc.
9.2.9. Genelux Corporation
9.2.10. OncoGenex Pharmaceuticals Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now